These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 23535272)

  • 1. crRNA and tracrRNA guide Cas9-mediated DNA interference in Streptococcus thermophilus.
    Karvelis T; Gasiunas G; Miksys A; Barrangou R; Horvath P; Siksnys V
    RNA Biol; 2013 May; 10(5):841-51. PubMed ID: 23535272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems.
    Chylinski K; Le Rhun A; Charpentier E
    RNA Biol; 2013 May; 10(5):726-37. PubMed ID: 23563642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA.
    Fonfara I; Richter H; Bratovič M; Le Rhun A; Charpentier E
    Nature; 2016 Apr; 532(7600):517-21. PubMed ID: 27096362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmable DNA cleavage in vitro by Cas9.
    Karvelis T; Gasiunas G; Siksnys V
    Biochem Soc Trans; 2013 Dec; 41(6):1401-6. PubMed ID: 24256227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cut site selection by the two nuclease domains of the Cas9 RNA-guided endonuclease.
    Chen H; Choi J; Bailey S
    J Biol Chem; 2014 May; 289(19):13284-94. PubMed ID: 24634220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Programmable RNA shredding by the type III-A CRISPR-Cas system of Streptococcus thermophilus.
    Tamulaitis G; Kazlauskiene M; Manakova E; Venclovas Č; Nwokeoji AO; Dickman MJ; Horvath P; Siksnys V
    Mol Cell; 2014 Nov; 56(4):506-17. PubMed ID: 25458845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Reconstitution and Crystallization of Cas9 Endonuclease Bound to a Guide RNA and a DNA Target.
    Anders C; Niewoehner O; Jinek M
    Methods Enzymol; 2015; 558():515-537. PubMed ID: 26068752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria.
    Gasiunas G; Barrangou R; Horvath P; Siksnys V
    Proc Natl Acad Sci U S A; 2012 Sep; 109(39):E2579-86. PubMed ID: 22949671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A scoutRNA Is Required for Some Type V CRISPR-Cas Systems.
    Harrington LB; Ma E; Chen JS; Witte IP; Gertz D; Paez-Espino D; Al-Shayeb B; Kyrpides NC; Burstein D; Banfield JF; Doudna JA
    Mol Cell; 2020 Aug; 79(3):416-424.e5. PubMed ID: 32645367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biogenesis pathways of RNA guides in archaeal and bacterial CRISPR-Cas adaptive immunity.
    Charpentier E; Richter H; van der Oost J; White MF
    FEMS Microbiol Rev; 2015 May; 39(3):428-41. PubMed ID: 25994611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assembling the Streptococcus thermophilus clustered regularly interspaced short palindromic repeats (CRISPR) array for multiplex DNA targeting.
    Guo L; Xu K; Liu Z; Zhang C; Xin Y; Zhang Z
    Anal Biochem; 2015 Jun; 478():131-3. PubMed ID: 25748774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric Guides Probe and Enhance Cas9 Biochemical Activity.
    Kartje ZJ; Barkau CL; Rohilla KJ; Ageely EA; Gagnon KT
    Biochemistry; 2018 May; 57(21):3027-3031. PubMed ID: 29746102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phylogeny of Cas9 determines functional exchangeability of dual-RNA and Cas9 among orthologous type II CRISPR-Cas systems.
    Fonfara I; Le Rhun A; Chylinski K; Makarova KS; Lécrivain AL; Bzdrenga J; Koonin EV; Charpentier E
    Nucleic Acids Res; 2014 Feb; 42(4):2577-90. PubMed ID: 24270795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type III-A CRISPR-Cas Csm Complexes: Assembly, Periodic RNA Cleavage, DNase Activity Regulation, and Autoimmunity.
    Jia N; Mo CY; Wang C; Eng ET; Marraffini LA; Patel DJ
    Mol Cell; 2019 Jan; 73(2):264-277.e5. PubMed ID: 30503773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Basis for Guide RNA Processing and Seed-Dependent DNA Targeting by CRISPR-Cas12a.
    Swarts DC; van der Oost J; Jinek M
    Mol Cell; 2017 Apr; 66(2):221-233.e4. PubMed ID: 28431230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C2c1-sgRNA Complex Structure Reveals RNA-Guided DNA Cleavage Mechanism.
    Liu L; Chen P; Wang M; Li X; Wang J; Yin M; Wang Y
    Mol Cell; 2017 Jan; 65(2):310-322. PubMed ID: 27989439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro enzymology of Cas9.
    Anders C; Jinek M
    Methods Enzymol; 2014; 546():1-20. PubMed ID: 25398333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9.
    Yang H; Patel DJ
    Mol Cell; 2017 Jul; 67(1):117-127.e5. PubMed ID: 28602637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR as a strong gene editing tool.
    Shen S; Loh TJ; Shen H; Zheng X; Shen H
    BMB Rep; 2017 Jan; 50(1):20-24. PubMed ID: 27616359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation and Stoichiometry of CRISPR-Cascade Complexes with Varying Spacer Lengths Revealed by Native Mass Spectrometry.
    Wittig S; Songailiene I; Schmidt C
    J Am Soc Mass Spectrom; 2020 Mar; 31(3):538-546. PubMed ID: 32008319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.